Comparison of two dose schedules of dichloromethotrexate (NSC-29630) in lung cancer

Cancer Chemother Rep. 1973 Feb;57(1):79-82.
No abstract available

MeSH terms

  • Blood Cell Count
  • Carcinoma, Bronchogenic / drug therapy*
  • Carcinoma, Bronchogenic / radiotherapy
  • Chlorine / administration & dosage
  • Chlorine / adverse effects
  • Chlorine / therapeutic use
  • Female
  • Humans
  • Lung Neoplasms / drug therapy*
  • Lung Neoplasms / radiotherapy
  • Male
  • Methotrexate / administration & dosage*
  • Methotrexate / adverse effects
  • Methotrexate / therapeutic use
  • Middle Aged
  • Neoplasm Metastasis

Substances

  • Chlorine
  • Methotrexate